SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as the market reacts to a recent analyst downgrade and the upcoming leadership transition with a new CEO, alongside plans to split into two independent companies by 2026. The community is deeply divided, with many seeing KHC as a severely undervalued, recession-proof dividend play ripe for accumulation, while others express skepticism about its growth prospects amidst perceived market manipulation. This discussion comes as some investors consider rotating from high-flying tech into defensive consumer staples.

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is drawing significant community attention within the volatile digital asset space, driven by highly speculative discussions around its future value. Enthusiasts are actively touting its potential, often referencing it alongside major cryptocurrencies as part of the broader conversation on rapidly emerging tokens.

USELESS

USELESS CRYPTO is trending as it gains traction from recent listings on major exchanges and expanded cross-chain capabilities via Chainlink CCIP. The community is actively discussing its potential for substantial market cap growth, fueled by perceived accumulation from large investors and embracing its self-aware "useless" branding as a unique value proposition.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending due to significant advancements in its pipeline, highlighted by positive long-term data for its Duchenne Muscular Dystrophy gene therapy, RGX-202, and the recent FDA Priority Review acceptance for RGX-121 in Hunter Syndrome with an upcoming PDUFA target. Adding to the momentum, a new strategic partnership has provided substantial upfront funding and potential future milestones, bolstering its financial strength. The investing community is actively discussing RGX-121's strong approval prospects and RGX-202's differentiated safety profile as a potential best-in-class treatment, particularly within the evolving gene therapy landscape.

PolySwarm

PolySwarm (NCT) is currently trending with strong community sentiment emphasizing its unique utility in AI-driven cybersecurity amidst rising global cyber threats. Many investors believe the token is undervalued, observing increased volume and whale accumulation as signs it's positioning for a significant breakout. The community is eagerly anticipating a sustained rally, hoping to move beyond past volatility as a broader altcoin season potentially emerges.

Avino Silver & Gold Mines Ltd. engages in the mining and exploration activities. It focuses on silver reserves in the Durango region of North Central Mexico. It operates through the Silver, Gold, and Copper segments. The company was founded on May 15, 1968 and is headquartered in Vancouver, Canada.

Avino Silver & Gold Mines Ltd.

Avino Silver & Gold Mines is trending as surging silver and gold prices, alongside strategic milestones like major index inclusions and advancements in the La Preciosa project, fuel investor interest. The community is actively debating the stock's current valuation, questioning why it isn't fully reflecting the robust precious metals market amidst widespread concerns of sector-wide manipulation. Strong fundamentals, including being debt-free and a reported partnership for future silver supply, are bolstering long-term bullish sentiment.

AXS is the governance token for the Axie Infinity game. Token holders will be able to shape and vote for the direction of the game universe. This is unlike traditional games where all decisions are made by the game developers. AXS holders will be able to stake their tokens to earn more AXS and even vote for governance proposals.

Axie Infinity

Axie Infinity (AXS) is drawing significant community attention, with discussions highlighting upcoming developments like Apple Vision Pro integration and a V4 engine launch. Traders are actively monitoring increasing volume and comparing current activity to its historical performance, reflecting broad optimism for its position within the expanding Web3 gaming and AI training sectors.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energy Corp (UEC) is experiencing strong bullish momentum, fueled by rising uranium spot prices and significant government support for the nuclear energy sector. The community is actively discussing UEC's strategic production expansions and robust financial health, underscoring uranium's critical role in meeting increasing global power demands, particularly from emerging technologies like AI data centers.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as it reports its first global comparable store sales increase in seven quarters, suggesting its "Back to Starbucks" strategy is gaining traction amidst broader economic pressures. Despite this positive sign, the company faces community debate over its Q4 earnings miss, persistent inflationary headwinds, rising labor costs, and an ongoing workers' strike. Investors are keenly watching whether recent strategic moves, including a new joint venture in China, can solidify a sustained turnaround against intense competition and perceived overvaluation.

Hut 8 Corp. operates as a Bitcoin miner that focuses on mining. It provides digital asset mining, hosting, and managed infrastructure operation services. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is currently trending due to its significant AI infrastructure partnership with Anthropic and Fluidstack, which includes a substantial 15-year data center lease with Google's financial backing. The community is actively discussing this strategic pivot, viewing Hut 8 as a potential leader in the evolving digital infrastructure sector and distinguishing it from traditional Bitcoin mining operations. This development is sparking conversations about the company's long-term growth and competitive positioning against other industry players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QRG Capital Management Inc. Reduces Position in Boston Scientific Corporation $BSX

QRG Capital Management Inc. cut its stake in Boston Scientific Corporation (NYSE:BSX - Free Report) by 10.2% in the third quarter, according to the company in its most recent disclosure with the...

ASR Vermogensbeheer N.V. Buys 18,640 Shares of Boston Scientific Corporation $BSX

ASR Vermogensbeheer N.V. boosted its stake in Boston Scientific Corporation (NYSE:BSX - Free Report) by 4.1% during the 3rd quarter, according to the company in its most recent disclosure with the...

Boston Scientific (NYSE:BSX) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Boston Scientific from a "hold" rating to a "buy" rating in a report on Saturday...

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates...

Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.

DexCom Stock Declines Following Strong Preliminary Q4 Results

DXCM posts strong preliminary Q4 and full-year 2025 revenue growth, beating estimates, though shares slip after the announcement.

Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround 

Boston Scientific (BSX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Boston Scientific (NYSE:BSX) Price Target Lowered to $100.00 at Oppenheimer

Oppenheimer cut their price target on Boston Scientific from $125.00 to $100.00 and set an "outperform" rating on the stock in a report on Friday...

Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening

HOLX launches Ultimate Defense, a new U.S. campaign that urges routine Pap + HPV screening to boost awareness and help curb rising underscreening.

Nordea Investment Management AB Buys 14,262 Shares of Boston Scientific Corporation $BSX

Nordea Investment Management AB raised its stake in Boston Scientific Corporation (NYSE:BSX - Free Report) by 11.1% during the third quarter, according to its most recent filing with the Securities...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Current Price	$88.48
Prev Close	$90.03
Open	$90.02
Dividend Yield	0.00%
50-Day Moving Average	$97.03
Beta	0.63
Avg. Volume	9.29M
PE Ratio	47.10

52-Week High	$109.50
52-Week Low	$85.98
Market Capitalization	$153.8B
EPS (Annual)	$1.25
Price to Book	5.58
Revenue Per Employee	$315,981.13
Enterprise Value/EBITDA	N/A

BSX
Boston Scientific Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BSX News

BSXBoston Scientific Corp.